Humacyte Inc Stock Performance
as on March 31, 2026 at 1:07 am IST
Day's Low
Day's High
$0.56$0.70
-1.82%
Downside
27.27%
Upside
52 Week's Low
52 Week's High
$0.67$2.93-21.49%
Downside
432.73%
Upside
Humacyte Inc share price movements today
- Previous Close
- $0.68
- Open
- $0.70
- Volume
- 7.2M
- Day's Low - High
- $0.56 - $0.70
- 52 Week Low - High
- $0.67 - $2.93
Humacyte Inc Historical Returns
- 1 Month Return
- -39.68 %
- 3 Month Return
- -33.11 %
- 1 Year Return
- -65.53 %
- 3 Year Return
- -76.78 %
- 5 Year Return
- 0 %
Humacyte Inc Stock Fundamentals & Key Indicators
Check Humacyte Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$147.3M
EPS (TTM)
-0.526
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-8.28
Industry PE ratio
0PEG Ratio
0EBITDA
-100.1M
Revenue (TTM)
2.0M
Profit Margin
0.00%
Return On Equity TTM
-249.75%
Humacyte Inc Stock Valuation
Track how Humacyte Inc P/E has moved over time to understand its valuation trends.
Humacyte Inc in the last 5 years
Lowest (-23.35x)
December 31, 2022
Industry (0.00x)
March 30, 2026
Today (-8.28x)
March 30, 2026
Highest (11.98x)
September 30, 2022
Today’s Price to Earnings Ratio: -8.28x
Humacyte Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Humacyte Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $147.3M | NA | -8.28 | 0.00% | |
| BUY | $42.1B | 134.86% | 136.79 | 8.45% | |
| BUY | $110.0B | 103.33% | 28.25 | 32.94% | |
| NA | $32.5B | NA | 115.05 | 5.37% | |
| BUY | $78.0B | 56.74% | 17.79 | 31.41% |
Stock Returns calculator for Humacyte Inc Stock including INR - Dollar returns
The Humacyte Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Humacyte Inc investment value today
Current value as on today
₹31,096
Returns
Returns from Humacyte Inc Stock
Dollar Impact
₹3,035 (+3.03%)
Analyst Recommendation on Humacyte Inc Stock
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Humacyte Inc. Average target price of $7
Humacyte Inc Share Price Target
Get share price movements and forecasts by analysts on Humacyte Inc.
What analysts predicted
92.14%UPSIDE
Target Price
$7
Current Price
$0.55
Analyzed by
12 Analysts
Target
$7.00
Humacyte Inc target price $7, a slight upside of 92.14% compared to current price of $0.55. According to 12 analysts rating.
Humacyte Inc Stock’s Investor Sentiment and Interest
Search interest for Humacyte Inc Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:34% versus previous 30 day period
Humacyte Inc Quarterly Profit & Loss
All numbers in Millions USD
Humacyte Inc Annual Profit & Loss
All numbers in Millions USD
Humacyte Inc Quarterly Cash Flow
All numbers in Millions USD
Humacyte Inc Annual Cash Flow
All numbers in Millions USD
Humacyte Inc News & Key Events
Today's Timeline - 09 February
Mon, 06:30 PM
-Humacyte announces DoD funding for biologic vascular repair technologies in traumatic injuries, enhancing support for its bioengineered blood vessels.
Insights on Humacyte Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 83.7%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 62.6% return, outperforming this stock by 139.4%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 753.0K → 467.0K (in $), with an average decrease of 38.0% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -17.51M → -24.80M (in $), with an average decrease of 41.7% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, HUMA stock has moved down by -20.5%
About Humacyte Inc
| Organisation | Humacyte Inc |
| Headquarters | 2525 East North Carolina Highway 54, Durham, NC, United States, 27713 |
| Industry | Healthcare |
| CEO | Dr. Laura E. Niklason M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Humacyte Inc
Name | Title |
|---|---|
Mr. Dale A. Sander | CFO, Chief Corporate Development Officer & Treasurer |
Ms. Sabrina Osborne GPHR, SPHR | Chief People Officer |
Dr. Shamik J. Parikh M.D. | Chief Medical Officer |
Ms. Lisa Molyneux | Executive Vice President of Enterprise Planning & Analysis |
Dr. Heather Connelly Ph.D. | Executive Vice President Regulatory Affairs & Quality |
Dr. Laura E. Niklason M.D., Ph.D. | Founder, President, CEO & Director |
FAQs
What is Humacyte Inc share price today?
Humacyte Inc share price today is $0.55 as on . Humacyte Inc share today touched a day high of $0.7 and a low of $0.56.
What is the 52 week high and 52 week low for Humacyte Inc share?
Humacyte Inc share touched a 52 week high of $2.93 on and a 52 week low of $0.67 on . Humacyte Inc stock price today i.e. is trending at $0.55,which is 81.23% down from its 52 week high and -17.69% up from its 52 week low.
What is Humacyte Inc's market capitalisation today?
Humacyte Inc market capitalisation is $0.00T as on .
How to invest in Humacyte Inc Stock (HUMA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Humacyte Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Humacyte Inc Shares that will get you 2.7273 shares as per Humacyte Inc share price of $0.55 per share as on March 30, 2026 at 7:37 pm IST.
What is the minimum amount required to buy Humacyte Inc Stock (HUMA) from India?
Indian investors can start investing in Humacyte Inc (HUMA) shares with as little as ₹94.702 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.02 in Humacyte Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Humacyte Inc share’s latest price of $0.55 as on March 30, 2026 at 7:37 pm IST, you will get 18.1818 shares of Humacyte Inc. Learn more about
fractional shares .